Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.
Behav Brain Funct. 2010 Jun 24;6:34. doi: 10.1186/1744-9081-6-34.
Behav Brain Funct. 2010.
PMID: 20576091
Free PMC article.
Clinical Trial.
Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.
Brams M, Giblin J, Gasior M, Gao J, Wigal T.
Brams M, et al.
Postgrad Med. 2011 May;123(3):99-108. doi: 10.3810/pgm.2011.05.2288.
Postgrad Med. 2011.
PMID: 21566420
Clinical Trial.
Item in Clipboard
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
Brown TE, Brams M, Gao J, Gasior M, Childress A.
Brown TE, et al.
Postgrad Med. 2010 Sep;122(5):7-17. doi: 10.3810/pgm.2010.09.2196.
Postgrad Med. 2010.
PMID: 20861583
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.